Early decisions in lymphoid development

Current Opinion in Immunology

Volumn 19, Issue 2, 2007, Pages 123-128

  Ye, Min ^a,b   Graf, Thomas ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR;

B LYMPHOCYTE; BONE MARROW CELL; CELL FATE; CELL LINEAGE; CELL POPULATION; ERYTHROID CELL; GRANULOCYTE; LYMPHOID CELL; MACROPHAGE; MEGAKARYOCYTE; MULTIPOTENT STEM CELL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; SYSTEMATIC REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; B-LYMPHOCYTES; CELL LINEAGE; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-7; LYMPHOPOIESIS; MICE; RECEPTORS, NOTCH; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 33847678449     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2007.02.007     Document Type: Review

References (51)

1. Kondo M., Weissman I.L., and Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91 (1997) 661-672
2. Akashi K., Traver D., Miyamoto T., and Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404 (2000) 193-197
3. + (LSK) population that has lymphoid-myeloid but no MegE differentiation potential, called LMPPs. It challenges the classic lineage differentiation model and raises the possibility that GM cells can be generated by way of two separate routes: one through CMPs and another through LMPPs.
4. ••], this study also suggests that there are two routes for the development of granulocytes and macrophages.
5. + early progenitors were found to retain MegE potential, suggesting that the restriction of MegE potential is not the first lineage differentiation step.
6. Lai A.Y., and Kondo M. Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med 203 (2006) 1867-1873. Based on Flt3 and VCAM1 expression, MPPs were sub-divided into three subsets. These have comparable lymphoid lineage differentiation potential in vivo but differ in their MegE and GM-forming capacities, supporting the concept of a progressive loss of differentiation potential during early hematopoiesis.
7. Igarashi H., Gregory S.C., Yokota T., Sakaguchi N., and Kincade P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17 (2002) 117-130
8. Allman D., Sambandam A., Kim S., Miller J.P., Pagan A., Well D., Meraz A., and Bhandoola A. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 4 (2003) 168-174
9. Schwarz B.A., and Bhandoola A. Circulating hematopoietic progenitors with T lineage potential. Nat Immunol 5 (2004) 953-960
10. Benz C., and Bleul C.C. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J Exp Med 202 (2005) 21-31. Using CCR9-GFP mice, this study identified a multipotent precursor present in bone marrow, blood and thymus. Single cells of the precursor give rise to T, B and dendritic cells. This newly identified cell subset, termed thymic multipotent precursor (TMP), represents the earliest T-cell progenitor in the postnatal thymus.
11. Lu M., Tayu R., Ikawa T., Masuda K., Matsumoto I., Mugishima H., Kawamoto H., and Katsura Y. The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRβ chains than fetal progenitors. J Immunol 175 (2005) 5848-5856
12. Balciunaite G., Ceredig R., and Rolink A.G. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. Blood 105 (2005) 1930-1936
13. Nichogiannopoulou A., Trevisan M., Neben S., Friedrich C., and Georgopoulos K. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med 190 (1999) 1201-1214
14. Fong I.C., Zarrin A.A., Wu G.E., and Berinstein N.L. Functional analysis of the human RAG 2 promoter. Mol Immunol 37 (2000) 391-402
15. Lee H.C., Shibata H., Ogawa S., Maki K., and Ikuta K. Transcriptional regulation of the mouse IL-7 receptor alpha promoter by glucocorticoid receptor. J Immunol 174 (2005) 7800-7806
16. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and Ikaros. Nat Rev Immunol 2 (2002) 162-174
17. DeKoter R.P., and Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288 (2000) 1439-1441
18. Anderson M.K., Sun X., Miracle A.L., Litman G.W., and Rothenberg E.V. Evolution of hematopoiesis: three members of the PU.1 transcription factor family in a cartilaginous fish, Raja eglanteria. Proc Natl Acad Sci USA 98 (2001) 553-558
19. Nutt S.L., Metcalf D., D'Amico A., Polli M., and Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med 201 (2005) 221-231
20. Medina K.L., Pongubala J.M., Reddy K.L., Lancki D.W., Dekoter R., Kieslinger M., Grosschedl R., and Singh H. Assembling a gene regulatory network for specification of the B cell fate. Dev Cell 7 (2004) 607-617
21. Iwasaki H., Somoza C., Shigematsu H., Duprez E.A., Iwasaki-Arai J., Mizuno S., Arinobu Y., Geary K., Zhang P., Dayaram T., et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106 (2005) 1590-1600
22. Singh H., Medina K.L., and Pongubala J.M. Contingent gene regulatory networks and B cell fate specification. Proc Natl Acad Sci USA 102 (2005) 4949-4953
23. Graf T. Differentiation plasticity of hematopoietic cells. Blood 99 (2002) 3089-3101
24. Cantor A.B., and Orkin S.H. Hematopoietic development: a balancing act. Curr Opin Genet Dev 11 (2001) 513-519
25. Warren L., Bryder D., Weissman I.L., and Quake S.R. Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci USA 103 (2006) 17807-17812
26. -/- fetal liver cultures, showing that the gene is not strictly required for B-cell commitment. However, B-cell formation with the mutant cells occurs at low efficiencies and delayed kinetics compared with wild-type cells, indicating that PU.1 facilitates B-cell development.
27. Krysinska H., Hoogenkamp M., Ingram R., Wilson N., Tagoh H., Laslo P., Singh H., and Bonifer C. A two-step, PU.1-dependent, mechanism for developmentally regulated chromatin remodelling and transcription of the c-fms gene. Mol Cell Biol 27 (2007) 878-887. Utilizing PU.1-deficient myeloid progenitors, this study suggests a two-step mechanism by PU.1 controls c-fms gene activation during development. The factor first binds to the c-fms promoter region to maintain its primed status in progenitor cells. It then binds to the enhancer region, together with other factors, to fully activate c-fms expression in differentiated myeloid cells.
28. Lazorchak A.S., Wojciechowski J., Dai M., and Zhuang Y. E2A promotes the survival of precursor and mature B lymphocytes. J Immunol 177 (2006) 2495-2504. In this article, it is reported that inactivation of E2A in B-lineage cells only modestly inhibits B-lineage gene expression. This suggests that E2A is not required for B-cell fate maintenance, in contrast to its established role in lineage commitment.
29. Seet C.S., Brumbaugh R.L., and Kee B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J Exp Med 199 (2004) 1689-1700
30. Smith E.M., Gisler R., and Sigvardsson M. Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression. J Immunol 169 (2002) 261-270
31. Kee B.L., and Murre C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med 188 (1998) 699-713
32. Maier H., Ostraat R., Gao H., Fields S., Shinton S.A., Medina K.L., Ikawa T., Murre C., Singh H., Hardy R.R., et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 5 (2004) 1069-1077
33. Kikuchi K., Lai A.Y., Hsu C.L., and Kondo M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J Exp Med 201 (2005) 1197-1203. In this article, the authors demonstrate that IL-7R signaling regulates B-cell fate specification by enhancing EBF expression through the activation of STAT5.
34. Dias S., Silva Jr. H., Cumano A., and Vieira P. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J Exp Med 201 (2005) 971-979. This study demonstrates that IL-7 signaling controls B-cell fate specification through the up-regulation of EBF.
35. - early B cell precursors. J Exp Med 203 (2006) 675-687
36. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol 22 (2004) 55-79
37. Ikawa T., Kawamoto H., Wright L.Y., and Murre C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20 (2004) 349-360
38. Schaniel C., Gottar M., Roosnek E., Melchers F., and Rolink A.G. Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood 99 (2002) 2760-2766
39. Hsu C.L., King-Fleischman A.G., Lai A.Y., Matsumoto Y., Weissman I.L., and Kondo M. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc Natl Acad Sci USA 103 (2006) 672-677
40. Xie H., Ye M., Feng R., and Graf T. Stepwise reprogramming of B cells into macrophages. Cell 117 (2004) 663-676
41. Iwasaki H., Mizuno S., Wells R.A., Cantor A.B., Watanabe S., and Akashi K. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity 19 (2003) 451-462
42. + subset of ETPs in the thymus that exhibits weak B-lineage potential. The generation and subsequent differentiation of ETPs was found to require Notch signaling. In contrast, circulating T-cell precursors were still detectable, even in the absence of Notch signaling, suggesting that Notch signals crucial for T-lineage development are required soon after the thymus is seeded.
43. Wilson A., MacDonald H.R., and Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 194 (2001) 1003-1012
44. Tan J.B., Visan I., Yuan J.S., and Guidos C.J. Requirement for Notch1 signals at sequential early stages of intrathymic T cell development. Nat Immunol 6 (2005) 671-679. In contrast to the previously described increased B-cell formation in Notch-knockout mice [43], this study reports that the B-cell potential of ETPs is not augmented under conditions that limit Notch1 activation. It suggests that weak Notch signals are sufficient to suppress B-cell production by thymus seeding cells before reaching the ETP stage and that higher levels are required for the proliferation and differentiation of ETPs.
45. Schmitt T.M., Ciofani M., Petrie H.T., and Zuniga-Pflucker J.C. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 200 (2004) 469-479
46. Schmitt T.M., and Zuniga-Pflucker J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17 (2002) 749-756
47. Taghon T.N., David E.S., Zuniga-Pflucker J.C., and Rothenberg E.V. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev 19 (2005) 965-978. Using clonal switch-culture analyses, this study showed that, for as long as one week after culturing fetal liver progenitors on OP9-DL1 stroma, progeny of some pluripotent progenitors still maintained B-cell potential. This suggests that continuous Notch signaling is required for the maintenance of T-cell development.
48. Anderson M.K., Hernandez-Hoyos G., Diamond R.A., and Rothenberg E.V. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126 (1999) 3131-3148
49. Anderson M.K., Weiss A.H., Hernandez-Hoyos G., Dionne C.J., and Rothenberg E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 16 (2002) 285-296
50. Laiosa C.V., Stadtfeld M., Xie H., de Andres-Aguayo L., and Graf T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 25 (2006) 731-744. This study shows that expression of the macrophage-associated transcription factors C/EBPα and PU.1 in fully committed pre-T cells converts the cells into functional macrophages or myeloid dendritic cells, respectively. The induced differentiation is inhibited by Notch signaling, indicating a reciprocal antagonism between C/EBPα and PU.1 on one hand and activated Notch on the other.
51. Franco C.B., Scripture-Adams D.D., Proekt I., Taghon T., Weiss A.H., Yui M.A., Adams S.L., Diamond R.A., and Rothenberg E.V. Notch/Delta signaling constrains reengineering of pro-T cells by PU.1. Proc Natl Acad Sci USA 103 (2006) 11993-11998